Agios to Webcast Conference Call of First Quarter 2021 Financial Results on April 29, 2021
April 15 2021 - 7:00AM
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field
of cellular metabolism to treat genetically defined diseases, today
announced that the company will host a conference call and live
webcast on Thursday, April 29, 2021 at 8:00 a.m. ET to report its
first quarter 2021 financial results and other business highlights.
A live webcast can be accessed under "Events &
Presentations" in the Investors section of the company's website at
www.agios.com. The conference call can be accessed by dialing
1-877-377-7098 (domestic) or 1-631-291-4547 (international) and
referring to conference ID 4497151. The webcast will be archived
and made available for replay on the company's website beginning
approximately two hours after the event.
About AgiosAgios is focused on discovering and
developing novel investigational medicines to treat genetically
defined diseases through scientific leadership in the field of
cellular metabolism. The company’s most advanced drug candidate is
a first-in-class pyruvate kinase R (PKR) activator, mitapivat, that
is currently being evaluated for the treatment of three distinct
hemolytic anemias. In addition to its active late-stage clinical
pipeline, Agios has multiple novel, investigational therapies in
clinical and preclinical development. For more information, please
visit the company’s website at www.agios.com.
ContactHolly Manning, 617-844-6630Senior
Director, Investor RelationsHolly.Manning@agios.com
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Apr 2023 to Apr 2024